Does Rallies track congressional trades in CHE?

Yes. Rallies tracks politician and congressional stock disclosures for CHE, including reported purchases, sales, dates, owners, and trade amounts when available.

Is CHE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CHE. It does not provide personalized investment advice.

CHE (Chemed Corporation) Stock Analysis - Politician Trades

Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of May 21, 2026, CHE trades at $441.61 with a market cap of $5.86B and a P/E ratio of 23.99. CHE moved +0.10% today. Year to date, CHE is +0.83%; over the trailing twelve months it is -24.05%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is neutral with an average price target of $446.50. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded CHE stock?

Recent politician trading activity in CHE includes disclosures from Byron Donalds, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

CHE Key Metrics

Key financial metrics for CHE
Metric	Value
Price	$441.61
Market Cap	$5.86B
P/E Ratio	23.99
EPS	$18.36
Dividend Yield	0.60%
52-Week High	$623.61
52-Week Low	$365.21
Volume	0
Avg Volume	0
Revenue (TTM)	$2.54B
Net Income	$259.78M
Gross Margin	32.38%

Congressional Trades in CHE

Byron Donalds sale CHE on Mar 6, 2025 (amount: $15.00K).
Tommy Tuberville sale (full) CHE on Sep 29, 2021 (amount: $15.00K) for Joint.
Tommy Tuberville purchase CHE on Mar 29, 2021 (amount: $15.00K) for Joint.

Latest CHE News

VITAS Launches Free Mother’s Day Grief Helpline; Chemed Presents May 12 Conference — May 5, 2026
Chemed Raises 2026 EPS Guidance to $24–24.75; Roto-Rooter Margin Drops to 22.5% — May 4, 2026
Chemed slides as Roto-Rooter margin pressure and divestiture talk outweigh raised outlook — Apr 27, 2026
Chemed jumps nearly 10% on Q1 beat, raised 2026 outlook, Roto-Rooter divestiture talk — Apr 26, 2026
Chemed rallies nearly 10% after Q1 beat, higher 2026 outlook, divestiture talk — Apr 25, 2026

Recent CHE Insider Trades

GRACE PATRICK P sold 60 (~$25.55K) on May 8, 2026.
MCNAMARA KEVIN J sold 2.00K (~$842.26K) on May 1, 2026.
MCNAMARA KEVIN J sold 1.50K (~$554.05K) on Mar 27, 2026.

CHE Analyst Consensus

4 analysts cover CHE: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $446.50.

Common questions about CHE

Which politicians traded CHE stock?: Recent politician trading activity in CHE includes disclosures from Byron Donalds, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in CHE?: Yes. Rallies tracks politician and congressional stock disclosures for CHE, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CHE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CHE. It does not provide personalized investment advice.